CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 22nd Annual ROTH OC Growth Stock Conference on Tuesday, March 16, 2010, at 3:00 p.m. PT (6:00 p.m. ET) at the Ritz-Carlton, Laguna Niguel in California.
